Search

Your search keyword '"Lazareva, Arina"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Lazareva, Arina" Remove constraint Author: "Lazareva, Arina"
42 results on '"Lazareva, Arina"'

Search Results

1. Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases

4. Maintenance therapy for early loss of B-cell aplasia after CD19 CAR T-cell therapy

5. Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

6. Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy

7. CD19/CD22 targeting with co-transduced CAR T-cells to prevent antigen negative relapse after CAR T-cell therapy of B-ALL

8. CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL

11. Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR T Cell Therapy for Relapsed/Refractory ALL

12. Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases

13. CD34+-selected stem cell boost can safely improve cytopenias following CAR T-cell therapy

17. 62 When EPR fixed the protocol problem

18. Outcomes of Children and Young Adults with Acute Lymphoblastic Leukaemia Administered Inotuzumab Pre CAR-T Therapy

19. ALL Maintenance Treatment for Early Loss of B-Cell Aplasia after Tisagenlecleucel Therapy

20. Epstein–Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV

21. Graft‐ versus ‐host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation

22. EBV deletions as biomarkers of response to treatment of Chronic Active Epstein Barr Virus

26. EBV deletions as biomarkers of response to treatment of Chronic Active Epstein Barr Virus

29. Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial

30. Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

31. Delaying haematopoietic stem cell transplantation in children with viral respiratory infections reduces transplant‐related mortality

33. HLA B27 allele types in homogeneous groups of juvenile idiopathic arthritis patients in Latvia

34. Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial.

35. Delaying haematopoietic stem cell transplantation in children with viral respiratory infections reduces transplant‐related mortality.

42. Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two: Genoa, Italy. 28 September – 01 October 2016

Catalog

Books, media, physical & digital resources